Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20017632HPVENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS20017633HPVENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS20044433HPVENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS44017734HTLV-1ENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS44001341HTLV-1ENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS44034794HTLV-1ENSG00000257365.8protein_codingFNTBNoNo2342P49356
TVIS44049552HTLV-1ENSG00000257365.8protein_codingFNTBNoNo2342P49356
TCGA Plot Options
Drug Information
GeneFNTB
DrugBank IDDB07780
Drug NameFarnesyl diphosphate
Target IDBE0002372
UniProt IDP49356
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsExperimental
Direct ClassificationSesquiterpenoids
SMILESCC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O
PathwaysCerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Hyper-IgD Syndrome; Hereditary Coproporphyria (HCP); Porphyria Variegata (PV); Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hypercholesterolemia; Acute Intermittent Porphyria; Risedronate Action Pathway; Mevalonic Aciduria; Porphyrin Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; CHILD Syndrome; Congenital Erythropoietic Porphyria (CEP) or Gunther Disease; Cholesteryl Ester Storage Disease; Lovastatin Action Pathway; Wolman Disease; Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway
PharmGKB
ChEMBLCHEMBL69330